51 related articles for article (PubMed ID: 19593743)
1. ZNF692 regulates nucleolar morphology by interacting with NPM1 and modifying its self-assembly properties.
Brown IN; Levario A; Jiang C; Stachera W; Rodriguez E; Hao YH; Woodruff JB; Lafita-Navarro MC; Conacci-Sorrell M
J Biol Chem; 2024 Mar; 300(3):105773. PubMed ID: 38382671
[TBL] [Abstract][Full Text] [Related]
2. Gold is gold even in mud: NPM1 mutations in T-AML.
Ustun C
Blood; 2023 Apr; 141(15):1784-1785. PubMed ID: 37052940
[No Abstract] [Full Text] [Related]
3. Deciphering the folding transition state structure and denatured state properties of nucleophosmin C-terminal domain.
Scaloni F; Federici L; Brunori M; Gianni S
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5447-52. PubMed ID: 20212148
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin in Its Interaction with Ligands.
Cela I; Di Matteo A; Federici L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664415
[TBL] [Abstract][Full Text] [Related]
5. Favorable outcomes of NPM1
Khan I; Kaempf A; Raghuwanshi S; Chesnokov M; Zhang X; Wang Z; Domling A; Tyner JW; Camacho C; Gartel AL
Blood Cancer J; 2023 Aug; 13(1):128. PubMed ID: 37607920
[No Abstract] [Full Text] [Related]
6. Identification of a novel NPM1 mutation in acute myeloid leukemia.
Yao Y; Lin X; Wang C; Gu Y; Jin J; Zhu Y; Wang H
Exp Hematol Oncol; 2023 Oct; 12(1):87. PubMed ID: 37794441
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a quenching probe method for detection of
Kawaguchi-Ihara N; Itoh M; Murohashi I; Tohda S
Oncol Lett; 2016 Apr; 11(4):2429-2432. PubMed ID: 27073492
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors.
Damiani D; Tiribelli M; Raspadori D; Sirianni S; Meneghel A; Cavalllin M; Michelutti A; Toffoletti E; Geromin A; Simeone E; Bocchia M; Fanin R
Oncotarget; 2015 Oct; 6(30):30212-21. PubMed ID: 26338961
[TBL] [Abstract][Full Text] [Related]
9. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
10. Two novel NPM1 mutations in a therapy-responder AML patient.
Pianta A; Fabbro D; Damiani D; Tiribelli M; Fanin R; Franzoni A; Romanello M; Tell G; Di Loreto C; Damante G
Hematol Oncol; 2010 Sep; 28(3):151-5. PubMed ID: 19593743
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
14. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
Zhang Y; Zhang M; Yang L; Xiao Z
Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
